In the KOPN-49 and REH experiments, where CHZ868 demonstrated synergistic effects in the tumor rechallenge test, IFN-γ and TNF secretion was also maintained during the third tumor rechallenge, even in REH cells with wild-type JAK2 (Fig. 3). This evidence concerns the gene JAK2 and neoplasm.